BB Biotech AG (BION.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.47B |
| Enterprise Value | 2.37B |
| P/E Ratio | 3.48 |
| PEG Ratio | 0 |
| Price/Sales Ratio | -48.14 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | -41.99 |
| Enterprise/EBITDA | 2.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -13.81 |
| Operating Margin | -13.83 |
AD
Management Effectiveness
| Return On Assets | 0.3 |
| Return On Equity | 0.33 |
Income Statement
| Revenue | 76.81M |
| Revenue/Share | -1.05 |
| Gross Profit | 76.76M |
| EBITDA | 578.64M |
| Net Income | 578.13M |
| Diluted EPS | 10.54 |
Balance Sheet
| Total Cash | 356.18M |
| Total Cash/Share | 6.46 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 47.75 |
Price History
| 52-Week Change | 61.28 |
| 52-Week High | 52 |
| 52-Week Low | 30.75 |
| Moving Average 50 Days | 45.38 |
| Moving Average 200 Days | 44.7 |
Statistics
| Average Volume | 76,429 |
| Shares Outstanding | 55.15M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 4.46 |
| Payout Ratio | 0.16 |
| Last Split Factor | 5:1 |
| Last Split Date | March 29, 2016 |
AD
